PALM BEACH GARDENS, Fla., June 27 /PRNewswire-FirstCall/ -- MediSys Corporation cited a recently published news release of a study commissioned by SCHERING-PLOUGH, the makers of Cialis(R), and GLAXO SMITH KLINE, the makers of Levtra(R), that shows a clear indication that The MaxLife Center For Men(TM) system has been -- and continues to be -- in the forefront of men’s health. A national survey of U.S. men ages 35 and older conducted by Harris Interactive and published earlier this month, showed that approximately 8 of every 10 men (82%) with high blood pressure (hypertension or HTN) were not aware of its connection to erectile dysfunction (ED), and many were unaware of the connection between ED and other medical conditions that commonly affect men, such as high cholesterol (86%) and diabetes (73%).
“These are important findings for the millions of men in the U.S. who suffer from hypertension, high cholesterol, and diabetes, as any of these medical conditions can lead to erectile dysfunction. In my clinical experience, men often feel more comfortable visiting the doctor for a condition such as hypertension. If more men understood the link between these medical conditions, which are treatable, they might have an easier time talking to their doctor,” said Dr. Matt Rosenberg, medical director at Mid- Michigan Health Centers in Jackson, MI.
The survey found that nearly half (44%) of men 35 and older said they would be more likely to talk to their doctors about ED if they were informed about its connection to other conditions such as hypertension, high cholesterol or diabetes. Results from the national survey further showed that men and physicians might not always be speaking the same language when discussing men’s health. In fact, although a majority of physicians were aware that diabetes (100%), hypertension (88%) and high cholesterol (66%) may lead to ED, most men said they were unaware of the link at the time of diagnosis with the respective conditions.
Joshua Konigsberg, President and CEO of MediSys Corporation, commented on the press release saying, “This study further substantiates what MediSys has been telling doctors for several years as we market the MaxLife Center for Men(TM). I’m thrilled to have such esteemed Fortune 500 pharmaceutical companies supporting our position and edifying our concept.”
To assist in this awareness, the Men’s Health Network has partnered with GlaxoSmithKline and Schering-Plough to launch, “Check Men’s Facts” a program to raise awareness of the link between ED and other common medical conditions and to improve communication between patients and their physicians.
Mr. Konigsberg added, “We believe it’s vitally important to spread the word and create awareness about the link between ED and underlying diseases. Hopefully, this awareness will prompt men to seek help from a qualified professional at an earlier stage in the disease migration cycle.”
About MediSys
MediSys Corporation provides medical diagnostic solutions to physicians in the internal medicine, family medicine and general practice markets. The Company’s innovative clinical programs are easily integrated into the physicians practice, are cost-effective and enhance patient care. These programs or “systems” enable doctors to provide superior medical diagnostics & treatment while significantly improving their revenues and profits.
Disclaimer Regarding Forward-Looking Statements: This announcement may contain certain forward-looking statements that are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such statements reflect management’s current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated. Forward-looking statements speak only as of the date the statement was made. The Company assumes no obligation to update forward-looking information to reflect actual results, changes in assumptions or changes in other factors affecting forward- looking information. If the Company does update any forward-looking statement, no inference should be drawn that the Company will make additional updates with respect to that statement or any other forward-looking statements.
Contact: Brian Gibson 800 Village Square Crossing Suite 201 Palm Beach Gardens, FL 33410 Tel: 561-622-5889 Fax: 561-656-2099 e-mail: investor-relations@medisyscorp.comwww.medisyscorp.com
MediSys Corporation
CONTACT: Brian Gibson for MediSys Corporation, +1-561-622-5889, or fax,+1-561-656-2099, investor-relations@medisyscorp.com
Web site: http://www.medisyscorp.com/
